Clin Neuropharmacol 2003
It inhibits both glycolysis and oxidative phosphorylation in these cells, influencing their function
Delivered as a cyclical, nonFDA-approved protocol with informed consent, the program layers nightly or nearnightly injections, labs (including IGF1), and a tailored training and nutrition plan
doi: 10.3389/fphar.2026.1740609 Received 06 November 2025 Revised 03 February 2026 Accepted 11 February 2026 Published 24 February 2026 Volume 17 - 2026 Edited by Ziyi Wang, Johns Hopkins University, United States Reviewed by Xue Xiaoyong, Beijing University of Chinese Medicine, China Yatan Li, Xinjiang Medical University, China Updates Copyright 2026 Pang, Jiang, Ge, Huang, Rao, Wang, Zhou, Lyu, Wang and Tan
Implementing home blood pressure monitoring into clinical practice